Ischemic%20stroke Signs and Symptoms

Signs and Symptoms

Introduction

Stroke or cerebrovascular disease is defined as a sudden onset of focal neurological deficit or any alteration in level of consciousness due to an underlying vascular pathology
- Brain involvement is evident clinically or as documented in imaging studies based on the onset of symptoms
Ischemic stroke is a type of stroke characterized by the sudden absence of blood supply to an area of the brain, spinal cord or retina secondary to a thrombus, emboli, or intracranial small vessel disease
Most common risk factors include hypertension and diabetes mellitus
Rapid evaluation is essential for use of time-sensitive treatments and to prevent further brain damage

Epidemiology

Second most common cause of mortality and disability worldwide
- Ischemic stroke accounts for 62% of all incident strokes worldwide
Incidence of stroke increases with age and doubles after 55 years of age
Lifetime risk of stroke is higher in females than in males

Pathophysiology of Ischemic Stroke

Significant impairment or interruption of blood supply to the brain due to decreased systemic perfusion, severe stenosis or occlusion of a blood vessel leads to metabolic and molecular alterations resulting in neuronal function loss and morphological damage

Signs and Symptoms

Common Presentation of Patients with Acute Ischemic Stroke

Left (Dominant) Hemisphere

Left gaze preference
Right visual field deficit
Right hemiparesis
Right hemisensory loss
Dysarthria
Aphasia (Broca’s, Wernicke’s, Global)
Apraxia
Visual agnosia

Right (Non-dominant) Hemisphere

Right gaze preference
Left visual field deficit
Left hemiparesis
Left hemisensory loss (hemi-inattention)
Neglect of left side
Dysarthria

Brainstem

Nausea/vomiting
Diplopia, dysconjugate gaze, gaze palsy, nystagmus
Dysarthria, dysphagia
Vertigo, syncope
Hemiparesis or quadriplegia
Sensory loss in hemibody or all 4 limbs
Decreased consciousness
Hiccups, abnormal respirations
Alexia or inability to understand words written

Cerebellum

Truncal/gait ataxia, limb ataxia
Dysarthria
Vertigo, nystagmus

Product Highlight - AJOVY

01 Dec 2021

Fremanezumab 225 mg/1.5 mL solution for injection (pre-filled syringe)

Tumour-treating fields – a versatile treatment modality for multiple cancer types

Dr. Uri Weinberg, Dr. David Tran, Prof. Thomas Seufferlein, 13 Dec 2021

Tumour-treating fields (TTFields) are a noninvasive cancer treatment modality, which first demonstrated clinical benefits in combination with chemotherapy in glioblastoma multiforme (GBM). At a webinar organized by the Hong Kong Cancer Therapy Society (HKCTS), experts discussed TTFields’ potential in other cancer types, including hepatocellular carcinoma (HCC) and pancreatic cancer, and the rationale for combining TTFields with immunotherapy.

TTFields use in special GBM populations and potential combination with immunotherapy

Dr. Alexander Grote, Prof. Michael Lim, 14 Feb 2023

Glioblastoma multiforme (GBM) is the most common and aggressive brain tumour with a very poor prognosis. Tumour-treating fields (TTFields) are a relatively new, noninvasive treatment for GBM, which delivers low-intensity alternating electric fields that disrupt cancer cell division. At a recent scientific meeting organized by the Hong Kong Neurosurgical Society, Dr Alexander Grote of the Department of Neurosurgery, University Hospital of Marburg, Germany, and Professor Michael Lim of the Department of Neurosurgery, Stanford University, US, discussed the evolving role of TTFields in managing patients with GBM.